Recent Posts

News, precision oncology
Congenica announces Early Access Program for its novel Precision Oncology Solution
Posted 19th January 2023

Congenica announces Early Access Program for its novel Precision Oncology Solution

Read More
News , NGS , oncology
Congenica awarded European contract to develop NGS analysis workflow in oncology
Posted 6th December 2022

Congenica awarded European contract to develop NGS analysis workflow in oncology

Read More
Patient Advocacy , genomics , RareDiseases , precision medicine
The Real Costs of Rare Disease
Posted 25th November 2022

The Real Costs of Rare Disease

Read More
News , PGx
Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems
Posted 9th November 2022

Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems

Read More
Blog , Patient Advocacy , RareDiseases
Genomics in South Africa
Posted 1st September 2022

Genomics in South Africa

Read More
News , TeamCongenica
Congenica gives employees ‘cost of living’ bonus
Posted 26th August 2022

Congenica gives employees ‘cost of living’ bonus

Read More
Pharmacogenomics: Personalised psychotropic prescribing in adults with intellectual disabilities
Posted 17th August 2022

Pharmacogenomics: Personalised psychotropic prescribing in adults with intellectual disabilities

Read More
News , partners
Congenica announces partnership with Avesthagen
Posted 11th August 2022

Congenica announces partnership with Avesthagen

Read More
Blog , Patient Advocacy , RareDiseases
Living with a rare disease in India
Posted 5th August 2022

Living with a rare disease in India

Read More
News , Blog , precision oncology
Collaborative development of novel Precision Oncology Solution
Posted 4th August 2022

Collaborative development of novel Precision Oncology Solution

Read More
Blog , Patient Advocacy , rare diseases
Reality Check of a 13th Birthday for a Caregiver
Posted 28th July 2022

Reality Check of a 13th Birthday for a Caregiver

Read More
1 2 3 4 5
... 23 next
News , precision oncology
Congenica announces Early Access Program for its novel Precision Oncology Solution
Posted 19th January 2023

Congenica announces Early Access Program for its novel Precision Oncology Solution

Read More
News , NGS , oncology
Congenica awarded European contract to develop NGS analysis workflow in oncology
Posted December Dec 6th 2022

Congenica awarded European contract to develop NGS analysis workflow in oncology

Read More
Patient Advocacy , genomics , RareDiseases , precision medicine
The Real Costs of Rare Disease
Posted November Nov 25th 2022

The Real Costs of Rare Disease

Read More
News , PGx
Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems
Posted November Nov 9th 2022

Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems

Read More
Blog , Patient Advocacy , RareDiseases
Genomics in South Africa
Posted September Sep 1st 2022

Genomics in South Africa

Read More
News , TeamCongenica
Congenica gives employees ‘cost of living’ bonus
Posted August Aug 26th 2022

Congenica gives employees ‘cost of living’ bonus

Read More
Pharmacogenomics: Personalised psychotropic prescribing in adults with intellectual disabilities
Posted August Aug 17th 2022

Pharmacogenomics: Personalised psychotropic prescribing in adults with intellectual disabilities

Read More
News , partners
Congenica announces partnership with Avesthagen
Posted August Aug 11th 2022

Congenica announces partnership with Avesthagen

Read More
Blog , Patient Advocacy , RareDiseases
Living with a rare disease in India
Posted August Aug 5th 2022

Living with a rare disease in India

Read More
News , Blog , precision oncology
Collaborative development of novel Precision Oncology Solution
Posted August Aug 4th 2022

Collaborative development of novel Precision Oncology Solution

Read More
Blog , Patient Advocacy , rare diseases
Reality Check of a 13th Birthday for a Caregiver
Posted July Jul 28th 2022

Reality Check of a 13th Birthday for a Caregiver

Read More
1 2 3 4 5
... 23 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.